China Pharma Holdings Inc. (AMEX: CPHI) has seen a rise in its stock price by 15.25 in relation to its previous close of 0.22. However, the company has experienced a 18.54% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-10-01 that PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, announced today the expansion of its Vertiva® platform, which will include a 10mL option to be presented at CPHI Milan in October. The Vertiva® easy-to-use platform can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-c.
Is It Worth Investing in China Pharma Holdings Inc. (AMEX: CPHI) Right Now?
The 36-month beta value for CPHI is also noteworthy at 0.73. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CPHI is 7.29M, and at present, short sellers hold a 4.24% of that float. The average trading volume of CPHI on October 03, 2024 was 237.27K shares.
CPHI’s Market Performance
CPHI’s stock has seen a 18.54% increase for the week, with a 35.91% rise in the past month and a -2.84% fall in the past quarter. The volatility ratio for the week is 15.32%, and the volatility levels for the past 30 days are at 11.90% for China Pharma Holdings Inc. The simple moving average for the past 20 days is 19.94% for CPHI’s stock, with a -22.84% simple moving average for the past 200 days.
Analysts’ Opinion of CPHI
Many brokerage firms have already submitted their reports for CPHI stocks, with Rodman & Renshaw repeating the rating for CPHI by listing it as a “Mkt Outperform.” The predicted price for CPHI in the upcoming period, according to Rodman & Renshaw is $6 based on the research report published on January 08, 2010 of the previous year 2010.
CPHI Trading at 23.17% from the 50-Day Moving Average
After a stumble in the market that brought CPHI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.80% of loss for the given period.
Volatility was left at 11.90%, however, over the last 30 days, the volatility rate increased by 15.32%, as shares surge +31.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.50% lower at present.
During the last 5 trading sessions, CPHI rose by +18.54%, which changed the moving average for the period of 200-days by -53.23% in comparison to the 20-day moving average, which settled at $0.2174. In addition, China Pharma Holdings Inc. saw -57.52% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CPHI
Current profitability levels for the company are sitting at:
- -0.67 for the present operating margin
- -0.29 for the gross margin
The net margin for China Pharma Holdings Inc. stands at -0.7. The total capital return value is set at -0.44. Equity return is now at value -74.89, with -29.39 for asset returns.
Based on China Pharma Holdings Inc. (CPHI), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 420.43.
Currently, EBITDA for the company is 1830.0 with net debt to EBITDA at -1.2. When we switch over and look at the enterprise to sales, we see a ratio of 1.24. The receivables turnover for the company is 22.04for trailing twelve months and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.84.
Conclusion
In summary, China Pharma Holdings Inc. (CPHI) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
